Treatment time, ease of use and cost associated with use of Equashield™, PhaSeal®, or no closed system transfer device for administration of cancer chemotherapy to a dog model-Reference-Cited by-同舟云学术

Treatment time, ease of use and cost associated with use of Equashield™, PhaSeal®, or no closed system transfer device for administration of cancer chemotherapy to a dog model

Published:2015-04-10 Issue:1 Volume:15 Page:163-173
ISSN:1476-5810
Container-title:Veterinary and Comparative Oncology
language:en
Short-container-title:Vet Comp Oncol

Author:

Kicenuik K.¹,Northrup N.¹,Dawson A.¹,Locke J.²,Villamil J. A.³,Chretin J.⁴,Sfiligoi G.⁵,Clifford C.⁶,Rosenberg M.⁷,Hamilton T.⁸,Regan R.⁸,Parsons-Doherty M.⁹,Mallett C.¹⁰,Philibert J.¹¹,Impellizeri J.¹²,Hofmeister E.¹

Affiliation:

1. Department of Small Animal Medicine and Surgery, College of Veterinary Medicine; University of Georgia; Athens GA USA

2. Southeast Veterinary Oncology; Orange Park FL USA

3. Animal Cancer Care Clinic; Ft. Lauderdale FL USA

4. VCA West Los Angeles Animal Hospital; Los Angeles CA USA

5. Wheat Ridge Animal Hospital; Wheat Ridge CO USA

6. Hope Veterinary Specialists; Malvern PA USA

7. Veterinary Cancer Group; Woodland Hills CA USA

8. BluePearl Georgia Veterinary Specialists; Sandy Springs GA USA

9. Department of Small Animal Medicine and Surgery; University of Guelph Ontario Veterinary College; Guelph Ontario Canada

10. Columbia River Veterinary Specialists; Vancouver WA USA

11. Portland Veterinary Specialists; Portland ME USA

12. Veterinary Oncology Services, NY; Middletown NY USA

Funder

Georgia CaRES

Publisher

Wiley

Subject

General Veterinary

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/vco.12148/fullpdf

Reference19 articles.

1. National Institute for Occupational Safety and Health 2004

2. Association of antineoplastic drug handling with acute adverse effects in pharmacy personnel;Valanis;American Journal of Hospital Pharmacy,1993

3. Leukaemia and reproductive outcomes among nurses handling anti-neoplastic drugs;Skov;British Journal of Industrial Medicine,1992

4. Mutagenicity in urine of nurses handling cytostatic drugs;Falck;Lancet,1979

5. National Institute for Occupational Safety and Health 2010

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Systematic Approach to Evaluating Closed System Drug-Transfer Devices During Drug Product Development;Journal of Pharmaceutical Sciences;2021-12

2. Effectiveness of Closed System Drug Transfer Devices in Reducing Leakage during Antineoplastic Drugs Compounding;International Journal of Environmental Research and Public Health;2021-07-28

3. Determination of Holdup Volume and Transient Contact Compatibility of Closed System Transfer Devices for a Reconstituted Lyophilized Drug Product;Journal of Pharmaceutical Sciences;2020-11

4. Overcoming Challenges of Implementing Closed System Transfer Device Clinical In-Use Compatibility Testing for Drug Development of Antibody Drug Conjugates;Journal of Pharmaceutical Sciences;2020-01

5. Review of economic data on closed system transfer drug for preparation and administration of hazardous drugs;European Journal of Hospital Pharmacy;2019-02-22